CENTRE ANTOINE LACASSAGNE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
Study of Metabolites Markers in Adjuvant Breast Cancer
Completed
- Conditions
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 52
- Registration Number
- NCT03367208
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, Cedex 2, France
Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study
Completed
- Conditions
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 60
- Registration Number
- NCT03325738
- Locations
- 🇫🇷
PEYRADE Frédéric, Nice, France
The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line
- Conditions
- Interventions
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 200
- Registration Number
- NCT03205735
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2018-01-29
- Lead Sponsor
- Centre Antoine Lacassagne
- Registration Number
- NCT03126487
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2023-11-09
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 47
- Registration Number
- NCT03121469
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
Not Applicable
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 74
- Registration Number
- NCT03121456
- Locations
- 🇫🇷
Centre antoine-LACASSAGNE, Nice, France
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)
Phase 1
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Centre Antoine Lacassagne
- Registration Number
- NCT03114280
- Locations
- 🇫🇷
PEYRADE Frédéric, Nice, France
ELR+CXCL Cytokines in Metastatic Kidney Cancers: Predictive Markers of Resistance to Sunitinib
Completed
- Conditions
- Interventions
- First Posted Date
- 2017-03-31
- Last Posted Date
- 2020-07-21
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 60
- Registration Number
- NCT03097601
- Locations
- 🇫🇷
Centre Antoine LACASSAGNE, Nice, France
Consequences of an Initial Treatment for Head and Neck Cancer on Swallowing Function: Impact on Nutritional Status
Completed
- Conditions
- First Posted Date
- 2017-03-03
- Last Posted Date
- 2017-04-07
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 240
- Registration Number
- NCT03068559
Modification of the Quality of Life Based on Objective Geriatric Tests
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-08-19
- Last Posted Date
- 2019-07-23
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 76
- Registration Number
- NCT02873533
- Locations
- 🇫🇷
Centre Antoine LACASSAGNE, Nice, France
© Copyright 2024. All Rights Reserved by MedPath